Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Abgenix submits IND for ABX-MA1 in metastatic melanoma

Jan. 9, 2002

FDA approves IND for Albuleukin to enter clinical trials in treatment of cancer

Jan. 8, 2002

CancerVax files IND application to conduct pivotal trials of Canvaxin in advanced colon cancer

Jan. 8, 2002

Antisoma and Abbott revise pemtumomab licensing agreement

Jan. 8, 2002

Therion Biologics' cancer vaccine enters phase I trial

Jan. 3, 2002

Positive phase I/II AlloMune results for end-stage lymphoma

Dec. 31, 2001

IL-12 gene therapy studied in Japan for inducing tumor immunity

Dec. 27, 2001

European MAA submitted for Onzar in the treatment of cutaneous T-cell lymphoma

Dec. 20, 2001

Humanized anti-HM1.24 MAb well tolerated in phase I trial in myeloma patients

Dec. 14, 2001

FDA approves Herceptin labeling changes to add survival data

Dec. 14, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...